USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Point-of-care Testing Growth Opportunities
Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem
15-Nov-2023
North America
Market Research
This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology
testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.
In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid
amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance
testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control
plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.
In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and
small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.
A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization
of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.
Author: Amartya Bose
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Scope of Analysis (continued)
Segmentation—Test Type
Segmentation—Care Continuum
Key Competitors
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Growth Restraints (continued)
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Test Type
Revenue Forecast by Region
Revenue Forecast by Care Continuum
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Pricing Trends and Forecast Analysis
Competitive Environment
POCT Across Different Therapy Areas
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Competitor Matrix—Therapy Areas
Competitor Matrix—Technology Mapping
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Immunochemistry POCT
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Molecular POCT Therapy Areas
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Opportunity 1: Molecular POCT
Growth Opportunity 1: Molecular POCT (continued)
Growth Opportunity 2: Multiplexing
Growth Opportunity 2: Multiplexing (continued)
Growth Opportunity 3: STI POCT
Growth Opportunity 3: STI POCT (continued)
Growth Opportunity 4: AMR POCT
Growth Opportunity 4: AMR POCT (continued)
Growth Opportunity 5: Routine POCT
Growth Opportunity 5: Routine POCT (continued)
Growth Opportunity 6: Smartphone POCT
Growth Opportunity 6: Smartphone POCT (continued)
Future of POCT in Care Continuum
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Amartya Bose |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Point Of Care Molecular Diagnostics |
| Keyword 2 | Poc Testing Trends |
| Keyword 3 | Point-Of-Care Testing Insights |
| Podcast | No |
| WIP Number | K973-01-00-00-00 |